Neogen Corp (NEOG)
11.94
-0.20
(-1.65%)
USD |
NASDAQ |
Apr 18, 16:00
11.93
-0.01
(-0.08%)
After-Hours: 20:00
Neogen Revenue (TTM): 929.24M for Feb. 29, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| February 29, 2024 | 929.24M |
| November 30, 2023 | 918.68M |
| August 31, 2023 | 919.08M |
| May 31, 2023 | 822.45M |
| February 28, 2023 | 720.73M |
| November 30, 2022 | 630.72M |
| August 31, 2022 | 531.20M |
| May 31, 2022 | 527.16M |
| February 28, 2022 | 514.49M |
| November 30, 2021 | 502.96M |
| August 31, 2021 | 487.44M |
| May 31, 2021 | 468.46M |
| February 28, 2021 | 450.11M |
| November 30, 2020 | 433.27M |
| August 31, 2020 | 426.07M |
| May 31, 2020 | 418.17M |
| February 29, 2020 | 418.86M |
| November 30, 2019 | 416.69M |
| August 31, 2019 | 415.98M |
| May 31, 2019 | 414.19M |
| February 28, 2019 | 412.54M |
| November 30, 2018 | 409.75M |
| August 31, 2018 | 403.35M |
| May 31, 2018 | 397.93M |
| February 28, 2018 | 385.34M |
| Date | Value |
|---|---|
| November 30, 2017 | 378.82M |
| August 31, 2017 | 368.84M |
| May 31, 2017 | 358.28M |
| February 28, 2017 | 352.83M |
| November 30, 2016 | 341.17M |
| August 31, 2016 | 330.06M |
| May 31, 2016 | 321.27M |
| February 29, 2016 | 309.81M |
| November 30, 2015 | 301.49M |
| August 31, 2015 | 290.34M |
| May 31, 2015 | 283.07M |
| February 28, 2015 | 271.72M |
| November 30, 2014 | 265.31M |
| August 31, 2014 | 256.46M |
| May 31, 2014 | 247.40M |
| February 28, 2014 | 236.15M |
| November 30, 2013 | 225.21M |
| August 31, 2013 | 216.35M |
| May 31, 2013 | 207.53M |
| February 28, 2013 | 200.07M |
| November 30, 2012 | 193.92M |
| August 31, 2012 | 188.08M |
| May 31, 2012 | 184.04M |
| February 29, 2012 | 179.10M |
| November 30, 2011 | 176.42M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
414.19M
Minimum
May 2019
929.24M
Maximum
Feb 2024
568.30M
Average
495.20M
Median
Revenue (TTM) Benchmarks
| Moderna Inc | 6.754B |
| SIGA Technologies Inc | 139.92M |
| Syros Pharmaceuticals Inc | 9.935M |
| Disc Medicine Inc | -- |
| Amylyx Pharmaceuticals Inc | 380.79M |